{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:44Z","timestamp":1790484344383,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81173008"],"award-info":[{"award-number":["81173008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2009CB930300"],"award-info":[{"award-number":["2009CB930300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Project for Excellent Talents of Liaoning Province","award":["LR20110028"],"award-info":[{"award-number":["LR20110028"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ajps.2016.05.006","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T23:47:00Z","timestamp":1470354420000},"page":"157-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Development of Liposome containing sodium deoxycholate to enhance oral bioavailability of itraconazole"],"prefix":"10.1016","volume":"12","author":[{"given":"Zhenbao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajps.2016.05.006_bib0010","first-page":"84","article-title":"Itraconazole nanosuspension for oral delivery: formulation, characterization and in vitro comparison with marketed formulation","volume":"18","author":"Nakarani","year":"2010","journal-title":"Daru"},{"key":"10.1016\/j.ajps.2016.05.006_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0939-6411(03)00063-8","article-title":"Intravenous itraconazole emulsions produced by SolEmuls technology","volume":"56","author":"Akkar","year":"2003","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0020","first-page":"1","article-title":"Formulation and evaluation of Itraconazole nanoemulsion for enhanced oral bioavailability","author":"Thakkar","year":"2015","journal-title":"J Microencapsul"},{"key":"10.1016\/j.ajps.2016.05.006_bib0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.colsurfb.2015.03.036","article-title":"Critical determinant of intestinal permeability and oral bioavailability of pegylated all trans-retinoic acid prodrug-based nanomicelles: chain length of poly (ethylene glycol) corona","volume":"130","author":"Li","year":"2015","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.ajps.2016.05.006_bib0030","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.ejpb.2013.03.002","article-title":"Increased dissolution and oral absorption of itraconazole\/Soluplus extrudate compared with itraconazole nanosuspension","volume":"85","author":"Zhang","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2014.06.059","article-title":"Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole","volume":"192","author":"Kumar","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2016.05.006_bib0040","first-page":"1","article-title":"Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions","author":"Lang","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0045","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3109\/03639041003652973","article-title":"Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing","volume":"36","author":"DiNunzio","year":"2010","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0050","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1211\/jpp.62.04.0006","article-title":"Development of an itraconazole-loaded gelatin microcapsule with enhanced oral bioavailability: physicochemical characterization and in-vivo evaluation","volume":"62","author":"Li","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.ajps.2016.05.006_bib0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/03639045.2011.616513","article-title":"Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability","volume":"38","author":"Miller","year":"2012","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2011.04.034","article-title":"Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility","volume":"413","author":"Mou","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2014.02.016","article-title":"Nanocrystal-based per-oral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox(R) is not realized in in vivo drug absorption","volume":"180","author":"Sarnes","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2016.05.006_bib0070","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3109\/03639045.2014.914528","article-title":"Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation","volume":"41","author":"Sun","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0075","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejpb.2012.11.003","article-title":"Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs.Case example: itraconazole","volume":"83","author":"Taupitz","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejps.2009.08.002","article-title":"Itraconazole\/TPGS\/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance","volume":"38","author":"Van Eerdenbrugh","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ajps.2016.05.006_bib0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jconrel.2006.10.001","article-title":"A mixed polymeric micellar formulation of itraconazole: characteristics, toxicity and pharmacokinetics","volume":"117","author":"Yi","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2016.05.006_bib0090","first-page":"754","article-title":"Optimized self-microemulsifying drug delivery systems (SMEDDS) for enhanced oral bioavailability of astilbin","volume":"66","author":"Mezghrani","year":"2011","journal-title":"Pharmazie"},{"key":"10.1016\/j.ajps.2016.05.006_bib0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10717541003667822","article-title":"Pharmacokinetics and biodistribution of itraconazole in rats and mice following intravenous administration in a novel liposome formulation","volume":"17","author":"Tang","year":"2010","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ajps.2016.05.006_bib0100","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4155\/tde.15.69","article-title":"Oral delivery of liposomes","volume":"6","author":"Wu","year":"2015","journal-title":"Ther Deliv"},{"issue":"6","key":"10.1016\/j.ajps.2016.05.006_bib0105","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/jphp.12551","article-title":"Effect of permeability enhancers on paracellular permeability of acyclovir","volume":"68","author":"Ates","year":"2016","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.ajps.2016.05.006_bib0110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/0310057X9101900218","article-title":"Assessment of a new infusion pump for epidural PCA","volume":"19","author":"Baldwin","year":"1991","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.ajps.2016.05.006_bib0115","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/S0264-410X(00)00537-5","article-title":"Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)","volume":"19","author":"Conacher","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ajps.2016.05.006_bib0120","first-page":"965","article-title":"Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt","volume":"6","author":"Guan","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.ajps.2016.05.006_bib0125","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1016\/j.biomaterials.2012.06.019","article-title":"Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance","volume":"33","author":"Wang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2016.05.006_bib0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2014.10.024","article-title":"Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation","volume":"197","author":"Han","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2016.05.006_bib0135","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1021\/acs.molpharmaceut.5b00010","article-title":"Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-beta-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2014.10.038","article-title":"Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-beta-cyclodextrin","volume":"477","author":"Liu","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0145","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1021\/bm501847u","article-title":"Enteric polymer based on pH-responsive aliphatic polycarbonate functionalized with vitamin E to facilitate oral delivery of tacrolimus","volume":"16","author":"Wang","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ajps.2016.05.006_bib0150","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.colsurfb.2015.02.039","article-title":"Rod shaped nanocrystals exhibit superior in vitro dissolution and in vivo bioavailability over spherical like nanocrystals: a case study of lovastatin","volume":"128","author":"Guo","year":"2015","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.ajps.2016.05.006_bib0155","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1021\/mp400282r","article-title":"Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism","volume":"10","author":"Lian","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0160","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijpharm.2013.06.034","article-title":"Profiling biopharmaceutical deciding properties of absorption of lansoprazole enteric-coated tablets using gastrointestinal simulation technology","volume":"453","author":"Wu","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0165","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1021\/mp4003249","article-title":"Mechanistic understanding of the effect of PPIs and acidic carbonated beverages on the oral absorption of itraconazole based on absorption modeling with appropriate in vitro data","volume":"10","author":"Fotaki","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-5173(01)00867-5","article-title":"Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability","volume":"229","author":"Kapsi","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2016.05.006_bib0175","first-page":"2801","article-title":"Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs","volume":"9","author":"Yin","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ajps.2016.05.006_bib0180","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.tips.2014.09.008","article-title":"Prodrug-based nanoparticulate drug delivery strategies for cancer therapy","volume":"35","author":"Luo","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ajps.2016.05.006_bib0185","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1039\/c2nr32867d","article-title":"The holistic 3M modality of drug delivery nanosystems for cancer therapy","volume":"5","author":"Sun","year":"2013","journal-title":"Nanoscale"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087616300563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087616300563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T22:45:39Z","timestamp":1589669139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1818087616300563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1818087616300563"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2016.05.006","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Liposome containing sodium deoxycholate to enhance oral bioavailability of itraconazole","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2016.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}